Subacute inflammatory demyelinating polyneuropathy (Q41361): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
A polineuropatia inflamatória desmielinizante subaguda (PIDS) é um transtorno sensorial e/ou motor simétrico progressivo subagudo caracterizado por fraqueza muscular com sensibilidade prejudicada, reflexos tendinosos ausentes ou diminuídos e proteínas do líquido cefalorraquidiano (LCR) elevadas. A PIDS é uma forma intermediária entre a síndrome de Guillain-Barré (SGS) e a polirradiculoneuropatia inflamatória desmielinizante crônica (PIDC).
description / endescription / en
 
Subacute inflammatory demyelinating polyneuropathy (SIDP) is a subacute progressive symmetric sensorial and/or motor disorder characterised by muscular weakness with impaired sensation, absent or diminished tendon reflexes and elevated cerebrospinal fluid (CSF) proteins. SIDP is an intermediate form between Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP).

Revision as of 07:29, 13 August 2026

Subacute inflammatory demyelinating polyneuropathy (SIDP) is a subacute progressive symmetric sensorial and/or motor disorder characterised by muscular weakness with impaired sensation, absent or diminished tendon reflexes and elevated cerebrospinal fluid (CSF) proteins. SIDP is an intermediate form between Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP).
Language Label Description Also known as
default for all languages
8C01.2
    English
    Subacute inflammatory demyelinating polyneuropathy
    Subacute inflammatory demyelinating polyneuropathy (SIDP) is a subacute progressive symmetric sensorial and/or motor disorder characterised by muscular weakness with impaired sensation, absent or diminished tendon reflexes and elevated cerebrospinal fluid (CSF) proteins. SIDP is an intermediate form between Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP).

      Statements